T1	Premise 43 166	A 25-year-old woman with a history of allergic bronchial asthma due to sensitization to grass pollens and atopic dermatitis
T2	Premise 168 313	She suddenly presents hypotension, tachycardia, urticaria and bronchospasm after ingesting peanuts and is transferred to the emergency department
T3	Claim 438 585	Intramuscular adrenaline, followed by an inhaled bronchodilator of the SABA type and intramuscular dexchlorpheniramine. Then request serum tryptase
T4	Claim 590 728	An inhaled SABA-type bronchodilator, followed by intramuscular dexchlorpheniramine and intramuscular adrenaline. Then order serum tryptase
T5	Claim 733 893	Intramuscular dexchlorpheniramine, followed by an inhaled bronchodilator of the SABA type and intramuscular adrenaline. Then request eosinophil cationic protein
T6	Claim 898 1058	Intramuscular adrenaline, followed by an inhaled bronchodilator of the SABA type and intramuscular dexchlorpheniramine. Then request eosinophil cationic protein
T7	Claim 1085 1163	The patient is suffering from anaphylactic shock secondary to peanut ingestion
R1	Support Ent1:T2 Ent2:T7	
T8	Claim 1165 1311	The treatment of anaphylaxis and anaphylactic shock of first choice is intramuscular adrenaline 1mg/ml (dose 0.01 mg/kg, in adults 0.5 mg maximum)
R2	Support Ent1:T7 Ent2:T8	
T9	Claim 1313 1501	Followed by symptomatic treatment to stabilize the airway with 100% high flow O2, ensure large caliber venous access, fluid replacement and continuous monitoring (HR, BP, SatO2 , diuresis)
R3	Support Ent1:T8 Ent2:T9	
R4	Support Ent1:T8 Ent2:T3	
T10	Claim 1503 1689	As adjuvant treatment, an inhaled bronchodilator such as SABA, intramuscular dexchlorpheniramine or corticosteroids such as hydrocortisone IV or methylprednisolone IV can be administered
R6	Support Ent1:T9 Ent2:T10	
R7	Support Ent1:T10 Ent2:T3	
T11	Claim 1691 1984	Adrenaline can be repeated at the same doses every 5 minutes a maximum of 3 times and if after 15 minutes there is no response, IV adrenaline infusion should be started, Glucagon (if treatment with beta-blockers), Atropine (if prolonged bradycardia) or Vasopressors (if refractory hypotension)
R5	Support Ent1:T10 Ent2:T11	
T12	Claim 1986 2178	The laboratory marker that should be requested if anaphylaxis is suspected is serum tryptase in the first hour for a basal determination and another at 4-6 hours to observe its elevation curve
R8	Support Ent1:T12 Ent2:T3	
T13	Claim 2180 2263	It is not an emergency marker but it is very useful for future allergological study
T14	Marker 2210 2213	but
T15	Treatment 438 556	Intramuscular adrenaline, followed by an inhaled bronchodilator of the SABA type and intramuscular dexchlorpheniramine
T16	Diagnostics 571 585	serum tryptase
T17	Treatment 590 701	An inhaled SABA-type bronchodilator, followed by intramuscular dexchlorpheniramine and intramuscular adrenaline
T18	Diagnostics 714 728	serum tryptase
T19	Treatment 733 851	Intramuscular dexchlorpheniramine, followed by an inhaled bronchodilator of the SABA type and intramuscular adrenaline
T20	Diagnostics 866 893	eosinophil cationic protein
T21	Treatment 898 1016	Intramuscular adrenaline, followed by an inhaled bronchodilator of the SABA type and intramuscular dexchlorpheniramine
T22	Diagnostics 1031 1058	eosinophil cationic protein
